The vascular biology of atherosclerosis and imaging targets

Journal of Nuclear Medicine

Volumn 51, Issue SUPPL.1, 2010, Pages

  Libby, Peter ^a,b   DiCarli, Marcelo ^a,b   Weissleder, Ralph ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Atherosclerosis; Segmental arterial stenosis; Vascular; Vascular biology

Indexed keywords

BLOOD CLOTTING FACTOR 13; CATHEPSIN K; CELL ADHESION MOLECULE; COLLAGEN; COLLAGENASE; CYTOKINE; FRACTALKINE; GELATINASE; GLUCOSE; HLA ANTIGEN CLASS 2; HYPOCHLOROUS ACID; INTEGRIN; LIPOCORTIN 5; LIPOPROTEIN; MATRIX METALLOPROTEINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PADGEM PROTEIN; PHOSPHATIDYLSERINE; PROTEINASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; THROMBOPLASTIN; VASCULAR CELL ADHESION MOLECULE 1; VITRONECTIN RECEPTOR; BIOLOGICAL MARKER;

APOPTOSIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ACTIVATION; ENDOTHELIUM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; INNATE IMMUNITY; MEMBRANE MICROPARTICLE; MOLECULAR IMAGING; MONOCYTE; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; ANIMAL; ARTERY; BIOLOGICAL MODEL; CHEMISTRY; DIAGNOSTIC IMAGING; DISEASE COURSE; IMAGE PROCESSING; INFLAMMATION; LEUKOCYTE; MACROPHAGE; METABOLISM; METHODOLOGY; PATHOLOGY; REVIEW; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; COLLAGEN; CONSTRICTION, PATHOLOGIC; DIAGNOSTIC IMAGING; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; LEUKOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; VASCULAR CELL ADHESION MOLECULE-1;

EID: 77953033326     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.109.069633     Document Type: Article

References (51)

1. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
2. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell. 2001;104:503-516.
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
4. Libby P. The pathogenesis of atherosclerosis. In: Kasper DL, Braunwald E, Fauci S, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Medicine. 16th ed. New York, NY: McGraw-Hill Companies, Inc.; 2005:1425-1430.
5. Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008;263:517-527.
6. Hartvigsen K, Chou M-Y, Hansen LF, et al. The role of innate immunity in atherogenesis. J Lipid Res. 2009;50(suppl):S388-S393.
7. Libby P. Lesion versus lumen. Nat Med. 1995;1:17-18.
8. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
9. Libby P. The molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-2850.
10. Davies MJ. Stability and instability: the two faces of coronary atherosclerosis. The Paul Dudley White Lecture, 1995. Circulation. 1996;94:2013-2020.
11. Parmar KM, Larman HB, Dai G, et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49-58.
12. Dai G, Vaughn S, Zhang Y, Wang ET, Garcia-Cardena G, Gimbrone MA Jr. Biomechanical forces in atherosclerosis-resistant vascular regions regulate endothelial redox balance via phosphoinositol 3-kinase/Akt-dependent activation of Nrf2. Circ Res. 2007;101:723-733.
13. Nahrendorf M, Jaffer FA, Kelly KA, et al. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation. 2006;114:1504-1511.
14. 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice. Circ Cardiovasc Imaging. 2009;2:331-338.
15. Davies MJ, Gordon JL, Gearing AJ, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993;171:223-229.
16. Ley K, Reutershan J. Leucocyte-endothelial interactions in health and disease. Handb Exp Pharmacol. 2006(176 pt 2):97-133.
17. Mestas J, Ley K. Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med. 2008;18:228-232.
18. Barger A, Beeuwkes R III, Lainey L, Silverman K. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. N Engl J Med. 1984;310:175-177.
19. Moulton KS. Angiogenesis in atherosclerosis: gathering evidence beyond speculation. Curr Opin Lipidol. 2006;17:548-555.
20. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
21. hi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007;117:195-205.
22. Swirski FK, Nahrendorf M, Wildgruber M, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009;325:612-616.
23. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
24. Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med. 2005;353:46-57.
25. Tsimikas S, Shaw PX. Non-invasive imaging of vulnerable plaques by molecular targeting of oxidized LDL with tagged oxidation-specific antibodies. J Cell Biochem Suppl. 2002;39:138-146. (Pubitemid 36176565)
26. Torzewski M, Shaw PX, Han KR, et al. Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vasc Biol. 2004;24:2307-2312.
27. Briley-Saebo KC, Shaw PX, Mulder WJ, et al. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008;117:3206-3215.
28. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
29. Rudd JHF, Hyafil F, Fayad ZA. Inflammation imaging in atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1009-1016.
30. Su H, Spinale FG, Dobrucki LW, et al. Noninvasive targeted imaging of matrix metalloproteinase activation in a murine model of postinfarction remodeling. Circulation. 2005;112:3157-3167.
31. Deguchi J, Aikawa M, Tung C-H, et al. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation. 2006;114:55-62.
32. Jaffer FA, Kim DE, Quinti L, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115:2292-2298.
33. Zhang J, Nie L, Razavian M, et al. Molecular imaging of activated matrix metalloproteinases in vascular remodeling. Circulation. 2008;118:1953-1960.
34. Jaffer FA, Libby P, Weissleder R. Optical and multimodality molecular imaging: insights into atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:1017-1024.
35. Ohshima S, Petrov A, Fujimoto S, et al. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J Nucl Med. 2009;50:612-617.
36. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1 β-converting enzyme. Am J Pathol. 1995;147:251-266.
37. Geng YJ, Libby P. Progression of atheroma: a struggle between death and procreation. Arterioscler Thromb Vasc Biol. 2002;22:1370-1380.
38. Littlewood TD, Bennett MR. Apoptotic cell death in atherosclerosis. Curr Opin Lipidol. 2003;14:469-475.
39. Clarke MC, Bennett MR. Cause or consequence: what does macrophage apoptosis do in atherosclerosis? Arterioscler Thromb Vasc Biol. 2009;29:153-155.
40. Geng Y-J, Wu Q, Muszynski M, Hansson G, Libby P. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-α, and interleukin-1-β. Arterioscler Thromb Vasc Biol. 1996;16:19-27.
41. Clarke MC, Figg N, Maguire JJ, et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med. 2006;12:1075-1080.
42. Isobe S, Tsimikas S, Zhou J, et al. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density- lipoprotein receptor-deficient mice with annexin A5. J Nucl Med. 2006;47:1497-1505.
43. Laufer EM, Winkens MHM, Narula J, Hofstra L. Molecular imaging of macrophage cell death for the assessment of plaque vulnerability. Arterioscler Thromb Vasc Biol. 2009;29:1031-1038.
44. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol. 2001;158:879-891.
45. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol. 2003;91(3A):12A-16A.
46. Hazen SL. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol. 2004;24:1143-1146.
47. Griendling KK. ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol. 2005;25:272-273.
48. Shepherd J, Hilderbrand SA, Waterman P, Heinecke JW, Weissleder R, Libby P. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem Biol. 2007;14:1221-1231.
49. National Heart Lung and Blood Institute. NHLBI Working Group. Translation of Cardiovascular Molecular Imaging Executive Summary. Available at: http://www.nhlbi.nih.gov/funding/inits/cardio-imaging.htm. Accessed March 29, 2010.
50. Libby P. Atherosclerosis imaging: a biological and clinical perspective. In: Di Carli MF, Kwong RY, eds. Techniques for Imaging the Heart: Cardiac MR and CT. Hoboken, NJ: Wiley-Blackwell; 2008:259-277.
51. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111:3481-3488.